ORIGINAL ARTICLE |
|
Year : 2013 | Volume
: 19
| Issue : 3 | Page : 331-336 |
|
Genetic and molecular analysis of the CLDN14 gene in Moroccan family with non-syndromic hearing loss
Majida Charif, Redouane Boulouiz, Amina Bakhechane, Houda Benrahma, Halima Nahili, Abdelmajid Eloualid, Hassan Rouba, Mostafa Kandil, Omar Abidi, Guy Lenaers, Abdelhamid Barakat
Département de Recherche Scientifique, Laboratoire de Génétique Moléculaire et Humaine, Institut Pasteur, 1, Place Louis Pasteur, C.P. 20360 Casablanca, Morocco
Correspondence Address:
Abdelhamid Barakat Département de Recherche Scientifique, Laboratoire de Génétique Moléculaire et Humaine Institut Pasteur, 1, Place Louis Pasteur, C.P. 20360 Casablanca Morocco
![Login to access the Email id](http://www.medknow.com/images/email.gif) Source of Support: None, Conflict of Interest: None
DOI: 10.4103/0971-6866.120828
![Get Permissions](http://www.medknow.com/journals/images/gp.gif)
|
|
Background: Hearing loss is the most prevalent human genetic sensorineural defect. Mutations in the CLDN14 gene, encoding the tight junction claudin 14 protein expressed in the inner ear, have been shown to cause non-syndromic recessive hearing loss DFNB29.
Aim: We describe a Moroccan SF7 family with non-syndromic hearing loss. We performed linkage analysis in this family and sequencing to identify the mutation causing deafness.
Materials and Methods: Genetic linkage analysis, suggested the involvement of CLDN14 and KCNE1 gene in deafness in this family. Mutation screening was performed using direct sequencing of the CLDN14 and KCNE1 coding exon gene.
Results: Our results show the presence of c.11C>T mutation in the CLDN14 gene. Transmission analysis of this mutation in the family showed that the three affected individuals are homozygous, whereas parents and three healthy individuals are heterozygous. This mutation induces a substitution of threonine to methionine at position 4.
Conclusion: These data show that CLDN14 gene can be i mplicated in the development of hearing loss in SF7 family; however, the pathogenicity of c.11C>T mutation remains to be determined. |
|
|
|
[FULL TEXT] [PDF]* |
|
![Email this article](/ServeContent?url=http%3A%2F%2Fwww.ijhg.com%2Ftemplates%2Ficon_mail.gif) |
|